Block Listing Six Monthly Return

RNS Number : 0177G

LungLife AI, INC

15 November 2022

 

LungLife AI, Inc.

("LungLife" or the "Company")

Block Listing Six Monthly Return

LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, makes the following six-monthly update on its block listing:

Name of applicant:		LungLife AI, Inc.
Name of scheme:		1.  2010 Stock Incentive Plan 2.  2020 Stock Incentive Plan 3.  2021 Omnibus Long-Term Incentive Plan
Number and class of securities originally admitted:		1,356,139 common shares of US $0.0001 each
Date of admission:		15 November 2021
Period of return:	From:	15 May 2022	To:	15 November 2022
Balance of unallotted securities under scheme(s) from previous return:		1.  480,775 2.  201,374 3.  673,990
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		1.  NIL 2.  NIL 3.  NIL
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		1.  5,192 2.  NIL 3.  NIL
Equals: Balance under scheme(s) not yet issued/allotted at end of period:		1.  475,583 2.  201,374 3.  673,990

Name of contact:	David Anderson, Chief Financial Officer
Telephone number of contact:	+ 44 (0)20 7933 8780 or  [e-mail]

For further information please contact:

LungLife AI, Inc.	www.lunglifeai.com
Paul Pagano, CEO	Via Walbrook PR
David Anderson, CFO
Investec Bank plc (Nominated Adviser & Broker)	Tel: [phone]
Daniel Adams / Virginia Bull / Cameron MacRitchie
Walbrook PR Limited	Tel: [phone] or  [e-mail]
Paul McManus / Alice Woodings / Phil Marriage	Mob: [phone]

 

END

 

 

BLRGPGUUGUPPGPU